Literature DB >> 30509386

The immunobiology of female predominance in primary biliary cholangitis.

Alessio Gerussi1, Laura Cristoferi1, Marco Carbone1, Rosanna Asselta2, Pietro Invernizzi3.   

Abstract

Primary biliary cholangitis (PBC) is an autoimmune liver disease with a striking female preponderance. The mechanisms behind this predominance are still to be elucidated, although multiple theories have been postulated and investigated. Among the proposed involved factors, sex hormones have been the first to be studied, but unfortunately data have been inconclusive or conflicting. Similarly, fetal microchimerism has received a huge attention in the past, but data in PBC have been unsatisfactory especially if compared to other autoimmune diseases like systemic lupus erythematosus. Studies focused on genetic factors have generated more intriguing and robust data, reporting a few abnormalities on the X chromosome in PBC patients. However, these data are able to explain only a part of the phenotypic variability attributed to the genetic component, and most importantly, need to be validated in larger series. More recently, a novel mice model of PBC, characterised by a constitutive expression of Interferon-γ (IFN-γ), has been developed and it is notable for being the first one with female predominance. At the same time, there has been a wide interest in the role of microbiome in health and disease, as well as in epigenetics, which have tried to explain differences in biological phenotypes not covered by genetics. The aim of this review is to outline established knowledge on the topic and try to provide novel perspectives on the potential future applications of newer techniques addressing microbiome and epigenome, in order to further understand the biology of sex divergence in PBC.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ARE-Del(−/−) mice; Autoimmunity; Epigenetics; Female preponderance; Primary biliary cholangitis; Sex chromosomes

Mesh:

Substances:

Year:  2018        PMID: 30509386     DOI: 10.1016/j.jaut.2018.10.015

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  3 in total

Review 1.  The Role of Epigenetics in Primary Biliary Cholangitis.

Authors:  Alessio Gerussi; Elvezia Maria Paraboschi; Claudio Cappadona; Chiara Caime; Eleonora Binatti; Laura Cristoferi; Rosanna Asselta; Pietro Invernizzi
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 2.  Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis.

Authors:  Chang Wang; Ying Shi; Xiaomei Wang; Heming Ma; Quan Liu; Yanhang Gao; Junqi Niu
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

3.  X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.

Authors:  Rosanna Asselta; Elvezia M Paraboschi; Alessio Gerussi; Heather J Cordell; George F Mells; Richard N Sandford; David E Jones; Minoru Nakamura; Kazuko Ueno; Yuki Hitomi; Minae Kawashima; Nao Nishida; Katsushi Tokunaga; Masao Nagasaki; Atsushi Tanaka; Ruqi Tang; Zhiqiang Li; Yongyong Shi; Xiangdong Liu; Ma Xiong; Gideon Hirschfield; Katherine A Siminovitch; Marco Carbone; Giulia Cardamone; Stefano Duga; M Eric Gershwin; Michael F Seldin; Pietro Invernizzi
Journal:  Gastroenterology       Date:  2021-03-04       Impact factor: 33.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.